NVCR Q1 2022 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q1 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$138M+2.1% YoY

Gross Profit

$110M79.8% margin

Operating Income

-$806,000-0.6% margin

Net Income

-$5M-3.4% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+3.3%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$9M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$714M

Stockholders' Equity

$436M

Cash & Equivalents

$191M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$138M	$135M	+2.1%
Gross Profit	$110M	$108M	+1.4%
Operating Income	-$806,000	-$88,000	-815.9%
Net Income	-$5M	-$4M	-12.6%

Geographic Segments

UNITED STATES

$97M71%

GERMANY

$19M14%

JAPAN

$9M6%

EMEA, Exculding Germany

$8M6%

CHINA

$4M3%